From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Q. I am dealing with a horrible decline from generic Wellbutrin XL. I’ve been on samples of the name brand and my symptoms slowly improved. The generic is definitely a problem. My insurance won’t ...

6.0.428 [C:\Program Files\dotnet\sdk] 8.0.413 [C:\Program Files\dotnet\sdk] 9.0.109 [C:\Program Files\dotnet\sdk] 9.0.306 [C:\Program Files\dotnet\sdk] If this is a report about a bug in an analyzer, ...

QTPIE turns the driving exam into a phone on the dashboard: its dual cameras and sensors watch road and driver, scoring speed, head-turns, and lane discipline while an AI voice guides each maneuver ...

WASHINGTON — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians ...

The Food and Drug Administration approved a new generic version of a pill used to terminate pregnancies, a decision that comes as the Department of Health and Human Services reviews the drug’s safety.

The decision enraged opponents of abortion, who have been pressuring the Trump administration to restrict access to abortion medication. By Pam Belluck The Food and Drug Administration has approved a ...

US Securities and Exchange Commission Chair Paul Atkins says the new listing standards will reduce barriers to access digital asset products and give investors more choice. ”This approval helps to ...

The Food and Drug Administration has approved Amneal’s sodium oxybate oral solution 500 mg/ml, which is a generic of Jazz Pharmaceuticals’ Xyrem. Amneal had previously been distributing an authorized ...

The Association for Accessible Medicines and the Biosimilars Council have released the 2025 U.S. Generic & Biosimilar Medicines Savings Report. AAM’s annual savings report highlights that generic and ...